Latham & Watkins advised Seres Therapeutics, while Mayer Brown represented Société des Produits Nestlé on the deal. Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading live biotherapeutics...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised EngageSmart, Fenwick & West advised the underwriters, Paul Weiss, Kirkland & Ellis LLP, Maples and Calder (Cayman) and Whalen, respectively, advised certain...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented MeiraGTx in the transaction. MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical-stage gene therapy company, announced a financing agreement with affiliates...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Brilliant Earth in the transaction. Brilliant Earth is a digitally native, omnichannel fine jewelry company and a global leader in ethically sourced fine...
You must be a Standard 1 Year member to access this content.
